Showing 1,461 - 1,480 results of 16,814 for search '"cancer"', query time: 0.12s Refine Results
  1. 1461
  2. 1462
  3. 1463

    Neutrophils: From Inflammatory Bowel Disease to Colitis-Associated Colorectal Cancer by Chen T, Liu J, Hang R, Chen Q, Wang D

    Published 2025-01-01
    Subjects: “…colitis-associated colorectal cancer…”
    Get full text
    Article
  4. 1464

    BARD1 deletion in a patient with suspected hereditary colorectal cancer by Nobue Takaiso, Issei Imoto, Akiyo Yoshimura, Akira Ouchi, Koji Komori, Hiroji Iwata, Yasuhiro Shimizu

    Published 2024-03-01
    “…Abstract Deleterious germline variants in the BRCA1-associated ring domain (BARD1) gene moderately elevate breast cancer risk; however, their potential association with other neoplasms remains unclear. …”
    Get full text
    Article
  5. 1465

    Correlation between SMADs and Colorectal Cancer Expression, Prognosis, and Immune Infiltrates by Ning Ding, Hongbiao Luo, Tao Zhang, Tianshu Peng, Yanru Yao, Yongheng He

    Published 2023-01-01
    “…In recent years, the incidence and mortality of colorectal cancer (CRC) are increasing, and the 5-year survival rate of advanced metastatic CRC is poor. …”
    Get full text
    Article
  6. 1466
  7. 1467

    Discovery and Evaluation of Polymorphisms in the and Promoter Regions for Risk of Korean Lung Cancer by Jae Sook Sung, Kyong Hwa Park, Seung Tae Kim, Yeul Hong Kim

    Published 2012-09-01
    “…We first discovered 2 novel polymorphisms (AKT2 -9826 C/G and AKT3 -811 A/G), and we confirmed 6 known polymorphisms (AKT2 -9473 C/T, AKT2 -9151 C/T, AKT2 -9025 C/T, AKT2 -8618G/A, AKT3 -675 A/-, and AKT3 -244 C/T) of the AKT2 and AKT3 promoter region in 24 blood samples of Korean lung cancer patients using direct sequencing. To evaluate the role of AKT2 and AKT3 polymorphisms in the risk of Korean lung cancer, genotypes of the AKT2 and AKT3 polymorphisms (AKT2 -9826 C/G, AKT2 -9473 C/T, AKT2 -9151 C/T, AKT2 -9025 C/T, AKT2 -8618G/A, and AKT3 -675 A/-) were determined in 360 lung cancer patients and 360 normal controls. …”
    Get full text
    Article
  8. 1468

    Historical Reconstruction of Astronaut Cancer Risk: Context for Recent Solar Minima by Tony C. Slaba

    Published 2021-10-01
    “…Using the most up‐to‐date models for characterizing the ambient GCR environment, physical interactions with shielding, and cancer risk, it is found that projected risks vary by only ±10% over all historical minima since 1750. …”
    Get full text
    Article
  9. 1469
  10. 1470
  11. 1471

    Deep learning to decode sites of RNA translation in normal and cancerous tissues by Jim Clauwaert, Zahra McVey, Ramneek Gupta, Ian Yannuzzi, Venkatesha Basrur, Alexey I. Nesvizhskii, Gerben Menschaert, John R. Prensner

    Published 2025-02-01
    “…We demonstrate that RiboTIE successfully recapitulates known findings and provides novel insights into the regulation of RNA translation in both normal brain and medulloblastoma cancer samples. Our results suggest that RiboTIE is a versatile tool that can significantly improve the accuracy and depth of Ribo-Seq data analysis, thereby advancing our understanding of protein synthesis and its implications in disease.…”
    Get full text
    Article
  12. 1472
  13. 1473

    Combination Therapy of PPAR𝛾 Ligands and Inhibitors of Arachidonic Acid in Lung Cancer by Jordi Tauler, James L. Mulshine

    Published 2008-01-01
    “…Lung cancer is the leading cause of cancer death in the United States and five-year survival remains low. …”
    Get full text
    Article
  14. 1474

    The Role of the PAX8/PPARγ Fusion Oncogene in Thyroid Cancer by Kimberly A. Placzkowski, Honey V. Reddi, Stefan K. G. Grebe, Norman L. Eberhardt, Bryan McIver

    Published 2008-01-01
    “…Thyroid cancer is uncommon and exhibits relatively low mortality rates. …”
    Get full text
    Article
  15. 1475
  16. 1476
  17. 1477
  18. 1478
  19. 1479
  20. 1480